From the Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA.
Private Practice Ophthalmology, Miami, FL.
J Clin Psychopharmacol. 2021;41(3):295-303. doi: 10.1097/JCP.0000000000001382.
PURPOSE/BACKGROUND: Several clinic-based and large population studies have associated a depression diagnosis or depression severity with dry eye disease (DED) or symptoms. On the other hand, several other large population studies have found that antidepressant use was also associated with DED. Unfortunately, many of the studies finding associations between depression and DED did not control for concomitant antidepressant use, whereas the ones that found associations between antidepressant use and DED did not control for severity of depression or other psychiatric indications for selective serotonin inhibitor use. The purpose of this review was to identify whether depression and antidepressants play an independent role from one another in the onset of DED.
METHODS/PROCEDURES: A systematic literature review was conducted searching for DED studies that adjusted for concomitant antidepressant use in depressed patients, that adjusted for depressive symptoms in patients taking antidepressants, and that enrolled depressed patients who were not taking psychiatric medications at the time of the study. Additionally, the prescribing information of marketed antidepressants was reviewed to determine rates of dry eyes reported during clinical trials.
FINDINGS/RESULTS: The literature review initially identified 43 studies with 13 fitting the inclusion criteria. Although these studies varied in their quality, 7 revealed statistically significant associations between depression and DED, whereas 7, including 1 randomized trial, revealed significant associations between antidepressants and DED. Sixteen percent of the antidepressant package inserts inspected reported DED symptoms as an infrequent risk.
IMPLICATIONS/CONCLUSIONS: This review suggests that independent of one another, both depression and antidepressant use are associated with DED.
目的/背景:几项基于临床和大型人群的研究表明,抑郁症的诊断或严重程度与干眼症(DED)或症状有关。另一方面,其他几项大型人群研究发现,抗抑郁药的使用也与 DED 有关。不幸的是,许多发现抑郁与 DED 之间存在关联的研究没有控制同时使用抗抑郁药,而那些发现抗抑郁药使用与 DED 之间存在关联的研究没有控制抑郁的严重程度或其他精神科选择性 5-羟色胺再摄取抑制剂使用的适应症。本综述的目的是确定抑郁症和抗抑郁药是否在 DED 的发病中彼此独立起作用。
方法/程序:进行了系统的文献综述,以寻找在抑郁患者中调整同时使用抗抑郁药、在服用抗抑郁药的患者中调整抑郁症状以及在研究时未服用精神药物的抑郁患者中调整的 DED 研究。此外,还审查了市售抗抑郁药的说明书,以确定临床试验期间报告的干眼症发生率。
发现/结果:文献综述最初确定了 43 项研究,其中 13 项符合纳入标准。尽管这些研究在质量上存在差异,但有 7 项研究显示抑郁症与 DED 之间存在统计学显著关联,而包括 1 项随机试验在内的 7 项研究显示抗抑郁药与 DED 之间存在显著关联。检查的 16%的抗抑郁药说明书报告了干眼症症状是一种不常见的风险。
意义/结论:本综述表明,抑郁症和抗抑郁药的使用彼此独立与 DED 相关。